Product Information
REFRESH RELIEVA PF 0.5-0.9% DP is a brand product labeled by Allergan, Inc., priced at $1.2541 per ML under NDC 00023663410. Its NADAC has been published 133 times since Mar 20, 2024.
Strength
5; 9 mg/mL; mg/mL
Manufacturer
Allergan, Inc.NDC
00023663410
Classification
Brand
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
CARBOXYMETHYLCELLULOSE SODIUM; GLYCERINApproval Type
OTC MONOGRAPH DRUG
FDA Application
M018On Market Since
7/26/2019
Pharmacological Classes
Price Statistics
The NADAC for REFRESH RELIEVA PF 0.5-0.9% DP has been published 133 times since Mar 20, 2024, and over the history we have for it it has risen 9.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2541 per ML |
|---|---|
| All-time high | $1.3176 (Feb 12, 2025) |
| All-time low | $1.1466 (Mar 20, 2024) |
| 52-week high | $1.2827 |
| 52-week low | $1.2539 |
| Median price | $1.2647 |
| Average price | $1.2669 |
| Largest weekly change | +8.6% (Apr 10, 2024) |
| Weeks tracked | 133 |
| Tracking since | Mar 20, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Carboxymethylcellulose sodium and Glycerin market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Allergan, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Carboxymethylcellulose sodium and Glycerin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Non-Standardized Chemical Allergen class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of REFRESH RELIEVA PF 0.5-0.9% DP?
The current National Average Drug Acquisition Cost (NADAC) for REFRESH RELIEVA PF 0.5-0.9% DP, manufactured by Allergan, Inc., is $1.2541 per ML (NDC 00023663410), effective Sep 30, 2026.
How has the price of REFRESH RELIEVA PF 0.5-0.9% DP changed over time?
Over the history we have for it, the NADAC for REFRESH RELIEVA PF 0.5-0.9% DP has risen 9.4%. It has been tracked across 133 weekly CMS publications since Mar 20, 2024.
What are the highest and lowest recorded NADAC prices for REFRESH RELIEVA PF 0.5-0.9% DP?
Since Mar 20, 2024, the NADAC for REFRESH RELIEVA PF 0.5-0.9% DP has ranged from a low of $1.1466 (Mar 20, 2024) to a high of $1.3176 (Feb 12, 2025), with a median of $1.2647 per ML.
Are there cheaper alternatives to REFRESH RELIEVA PF 0.5-0.9% DP?
No other NADAC-published product currently shares the active ingredient and strength of REFRESH RELIEVA PF 0.5-0.9% DP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures REFRESH RELIEVA PF 0.5-0.9% DP?
REFRESH RELIEVA PF 0.5-0.9% DP (NDC 00023663410) is labeled by Allergan, Inc., and CMS classifies it as a brand product.